How it Works
Doxorubicin hydrochloride is an antitumoral antibiotic (anthracyclines) that works by damaging the RNA or DNA that tells the cell how to copy itself during cell division. If the cells are unable to divide, they die. The faster the cells divide, the more likely it is that chemotherapy will kill them, causing the tumor to shrink.
How it’s Administered
Adriamycin is administered via an intravenous (IV) injection through a central line or a peripheral venous line, and the drug is given over several minutes. Doxorubicin can also be given by continuous infusion through a central catheter line.
Who Should Take Adriamycin
Adriamycin is currently approved for:
- Many types of cancer (breast, bladder, kidneys, ovaries, thyroid, stomach, lungs, bones, nerve tissues, joints, and soft tissue)
- Lymphoma Hodgkin and non-Hodgkin and certain types of leukemia, like acute myeloid leukemia.
- Multiple myeloma
Who Shouldn’t Take Adriamycin
- Pregnant women
- Patients with congestive heart failure
- Patients with bone marrow suppression
The Most Common Side Effects of Taking Adriamycin Include
- Pain in the site where the medication was given
- Nausea and vomiting
- Low blood counts (anemia, thrombocytopenia, neutropenia)
- Hair loss
Commonly Used in Multiple Myeloma With
- Bortezomib
- Lenalidomide and Dexamethasone
- Bortezomib, dexamethasone, and vincristine
Currently Being Tested in Multiple Myeloma With
- Steroids: Dexamethasone
- Chemotherapy drugs: Vincristine, Cisplatin, Cyclophosphamide, Etoposide, Melphalan
- Immunomodulators agents: Lenalidomide, Thalidomide
- Proteasome inhibitors: Bortezomib, Carfilzomib, Ixazomib
- Selective inhibitor of nuclear export (SINE): Selinexor
- Monoclonal antibodies: Daratumumab
Commonly Used in Acute Myeloid Leukemia With
- Cytarabine
- Venetoclax
Currently Being Tested in Acute Myeloid Leukemia With
- Cytarabine
- Venetoclax
Differences between Doxil and Rubex
- Doxil modulates the toxicity of traditional doxorubicin, in particular, the cardiac effects associated with anthracycline antitumor drugs
Learn more about your treatments in Cure Hub
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
Thanks to our HealthTree Community for Multiple Myeloma Sponsors:
![Johnson and Johnson](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FJohnson%20&%20Johnson%20Logo_64b18f59-85c9-4c20-a5ff-3842e69d8066.jpg?alt=media)
![Sanofi](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FSanofi%20updated%202023_d25a8d12-4f09-410c-9eb1-1e725b0b7c3e.jpg?alt=media)
![Pfizer](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FPfizer%20Logo%202024_50ae4587-5fdc-48e2-9a52-21651c643494.png?alt=media)
![Genentech](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/admin%2Fpublic%2Fshared%2FGenentech_Logo-700x182_e3c64168-dcf4-4540-9e9d-26500b26920a.png?alt=media)
![Regeneron](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRegeneron_dec43aa4-fe53-4d5a-9b7f-4170101b47f9.webp?alt=media)
![Adaptive](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FAdaptive%20Logo%204.2023_e0d11d37-8b31-4c88-a0fc-4d07efc9b16b.png?alt=media)